Abstract
In vitro studies and limited clinical data suggest that interleukin-2, a T-cell-derived lymphokine, may favorably affect immunologic responses during HIV infection. In this study, NIH investigators treated 25 HIV-infected patients with 5-day continuous infusions of …
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have